高级检索
当前位置: 首页 > 详情页

Overall survival and disease-free survival prediction in Chinese women with breast cancer aged 70 years or older by using nomograms

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc 1, Tianjin, Peoples R China [2]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [3]Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China [4]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [5]Second Cent Hosp Baoding, Dept Gen Surg, Baoding, Peoples R China [6]Second Hosp Chifeng, Dept Gen Surg, Chifeng, Peoples R China [7]Hebei Med Univ, Hosp 4, Breast Canc Ctr, Shijiazhuang, Peoples R China
出处:
ISSN:

关键词: breast cancer disease-free survival elderly nomogram overall survival

摘要:
PurposeBy analyzing the existing data of this study, a prediction tool for the overall breast cancer survival and disease-free survival (DFS) of elderly women was established.Patients and MethodsClinicopathologic data were collected from elderly women with BC who were admitted to the Tianjin Medical University Cancer Institute and Hospital from August 2014 to December 2017. Independent prognostic factors for BC in elderly patients were confirmed using the Cox proportional hazards model. Nomograms were developed with these factors for predicting the 3- and 5-year overall survival (OS) as well as DFS. The nomograms' discrimination ability and calibration were assessed through the area under the curve (AUC), concordance index (C-index), decision curve analysis (DCA), and calibration plots.ResultsWe enroled 889 elderly patients with BC, and the results showed that the 3-year OS rate was 93.4% (95%CI = 91.8%-95.1%), the 3-year DFS rate was 87.8% (95%CI = 85.7%-90.0%), the 5-year OS rate was 85.6% (95%CI = 83.3%-87.9%), and the 5-year DFS rate was 80.1%(95%CI = 77.5%-82.8%). The corrected C-indices of the OS and DFS nomograms were 0.799 and 0.667, respectively (95%CI = 0.767-0.830 and 0.632-0.702, respectively). Relatively high AUC values were shown by the nomograms for estimating OS and DFS. The DCA revealed that the constructed nomograms had net benefits for clinical application. The calibration curves demonstrated an excellent correspondence between the data predicted by the nomograms and the actual survival data. Survival curves indicated that risk stratification could differentiate OS and DFS.ConclusionsThis study developed novel and practical nomograms for individual prediction of DFS and OS in elderly BC patients. These nomograms can predict 3- and 5-year OS as well as DFS in the elderly BC patient population, thereby enabling personalized risk assessment and risk-based therapy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2025]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科 4 区 卫生保健与服务 4 区 医学:信息
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科 4 区 卫生保健与服务 4 区 医学:信息
JCR分区:
出版当年[2024]版:
Q2 MEDICINE, GENERAL & INTERNAL Q3 HEALTH CARE SCIENCES & SERVICES Q3 MEDICAL INFORMATICS
最新[2024]版:
Q2 MEDICINE, GENERAL & INTERNAL Q3 HEALTH CARE SCIENCES & SERVICES Q3 MEDICAL INFORMATICS

影响因子: 最新[2024版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc 1, Tianjin, Peoples R China [2]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [3]Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China [4]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [5]Second Cent Hosp Baoding, Dept Gen Surg, Baoding, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc 1, Tianjin, Peoples R China [2]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [3]Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China [4]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China [*1]Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc 1, Huan Hu Xi Rd, Tianjin 300060, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号